[go: up one dir, main page]

PE20090445A1 - Inhibidores de produccion de beta amiloide - Google Patents

Inhibidores de produccion de beta amiloide

Info

Publication number
PE20090445A1
PE20090445A1 PE2008001176A PE2008001176A PE20090445A1 PE 20090445 A1 PE20090445 A1 PE 20090445A1 PE 2008001176 A PE2008001176 A PE 2008001176A PE 2008001176 A PE2008001176 A PE 2008001176A PE 20090445 A1 PE20090445 A1 PE 20090445A1
Authority
PE
Peru
Prior art keywords
substituted
beta amyloid
amyloid production
production inhibitors
thiofen
Prior art date
Application number
PE2008001176A
Other languages
English (en)
Inventor
Thomas J Caggiano
Koi M Morris
Boyd L Harrison
Iii Anthony F Kreft
Dennis M Kubrak
Dane M Springer
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20090445A1 publication Critical patent/PE20090445A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/17—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE R1 ES ARILO SUSTITUIDO O NO, HETEROARILO SUSTITUIDO O NO; R2 ES HALOALQUILO SUSTITUIDO O NO; R3 ES ARILO SUSTITUIDO O NO, HETEROARILO SUSTITUIDO O NO. SON COMPUESTOS PREFERIDOS: 5-CLORO-N-[3,3,3-TRIFLUORO-1-(HIDROXIMETIL)-2-FENILPROPIL]TIOFEN-2-SULFONAMIDA; 5-CLORO-N-[(1S,2S)-2-(DIFLUOROFENIL)-3,3,3-TRIFLUOR-1-(HIDROXIMETIL)PROPIL]TIOFEN-2-SULFONAMIDA; ENTRE OTROS. REFERIDA TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION. DICHOS COMPUESTOS SON INHIBIDORES DE LA PRODUCCION DE BETA AMILOIDE, UTILES EN EL TRATAMIENTO DE ALZHEIMER
PE2008001176A 2007-07-16 2008-07-14 Inhibidores de produccion de beta amiloide PE20090445A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95967507P 2007-07-16 2007-07-16

Publications (1)

Publication Number Publication Date
PE20090445A1 true PE20090445A1 (es) 2009-05-18

Family

ID=39769171

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001176A PE20090445A1 (es) 2007-07-16 2008-07-14 Inhibidores de produccion de beta amiloide

Country Status (9)

Country Link
US (1) US20090023801A1 (es)
EP (1) EP2193117A1 (es)
JP (1) JP2010533723A (es)
CA (1) CA2693959A1 (es)
CL (1) CL2008002060A1 (es)
PA (1) PA8789701A1 (es)
PE (1) PE20090445A1 (es)
TW (1) TW200911779A (es)
WO (1) WO2009012205A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2517155A1 (en) * 2003-03-31 2004-10-28 Wyeth Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
PA8811701A1 (es) * 2008-01-11 2009-08-26 Wyeth Corp COMPOSICIONES QUE CONTIENEN DERIVADOS DE ARIL SULFONONAMIDA QUE CONTIENEN O-SULFATO Y O-FOSFATO,ÚTILES COMO INHIBIDORES DE ß-AMILOIDE
CA2759187A1 (en) * 2009-04-03 2010-10-07 Medisyn Technologies, Inc. Compositions for treatment of alzheimer's disease
US9156814B2 (en) * 2011-04-21 2015-10-13 Hong Kong Baptist University Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation
CN104649857B (zh) * 2013-11-19 2017-05-17 中国科学院上海有机化学研究所 三氟甲基取代的叠氮、胺及杂环类化合物及制备方法
TW202126617A (zh) 2019-09-20 2021-07-16 美商富曼西公司 間二醯胺類殺蟲劑

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104559A1 (en) * 1998-03-27 2003-06-05 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
UA74849C2 (en) * 2000-11-17 2006-02-15 Lilly Co Eli Lactam
HUP0303857A3 (en) * 2000-12-13 2007-07-30 Wyeth Corp Heterocyclic sulifonamide inhibitors of beta amyloid production
NZ536665A (en) * 2002-06-11 2006-11-30 Wyeth Corp Use of substituted phenylsulfonamide as inhibitors of beta amyloid production
CA2517155A1 (en) * 2003-03-31 2004-10-28 Wyeth Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
WO2005073198A1 (en) * 2004-01-16 2005-08-11 Wyeth Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
WO2007098029A1 (en) * 2006-02-17 2007-08-30 Wyeth Methods for preparing sulfonamide substituted alcohols and intermediates thereof
CA2637615A1 (en) * 2006-02-17 2007-08-30 Wyeth Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
US7476762B2 (en) * 2006-04-21 2009-01-13 Wyeth Methods for preparing sulfonamide compounds
US7550629B2 (en) * 2006-04-21 2009-06-23 Wyeth Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors

Also Published As

Publication number Publication date
US20090023801A1 (en) 2009-01-22
PA8789701A1 (es) 2009-04-23
JP2010533723A (ja) 2010-10-28
WO2009012205A1 (en) 2009-01-22
EP2193117A1 (en) 2010-06-09
CA2693959A1 (en) 2009-01-22
CL2008002060A1 (es) 2008-11-21
TW200911779A (en) 2009-03-16

Similar Documents

Publication Publication Date Title
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
EA200900066A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил) -d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
EA200971104A1 (ru) Производные бензимидазола
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
BR112014015363A8 (pt) derivados de ácido alfa-amino borônico, inibidores de imunoproteassoma seletivos
EA200500203A1 (ru) Новый способ синтеза и новая кристаллическая форма агомелатина и фармацевтические композиции, которые её содержат
NO20090328L (no) Nye forbindelser 385
EA201071019A1 (ru) Кристаллические формы производных фениламинопиримидина
PE20091843A1 (es) Inhibidores de catepsina c
CY1116885T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου
AR066972A1 (es) Derivados azapeptidicos
ATE440833T1 (de) Antithrombotische diamide
MEP41408A (en) Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
PE20090445A1 (es) Inhibidores de produccion de beta amiloide
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
NO20070089L (no) DPP-IV inhibitorer
EA200700901A1 (ru) Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии
EA200901474A1 (ru) Соли [4-(6-фтор-7-метиламино-2,4-диоксо-1,4-дигидро-2н-хиназолин-3-ил)фенил]-5-хлортиофен-2-илсульфонилмочевины в различных кристаллических формах и фармацевтические композиции на их основе
DE502005008057D1 (de) Substituierte cyclopenten-verbindungen
PH12014501181A1 (en) N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
SE0403086D0 (sv) Compounds
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их

Legal Events

Date Code Title Description
FX Voluntary withdrawal